All posts by PIER MARIA FORNASARI

PIER MARIA FORNASARI
2023-11-10

FDA Approves First Treatment for Patients with Rare Congenital Thrombotic Thrombocytopenic Purpura

The U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains deeply committed in our efforts to help facilitate

Read More

No Comments InRARE DISEASES
PIER MARIA FORNASARI
2023-11-10

November the 10th Updated living WHO guideline on drugs for covid-19

November the 10th a panel of international experts representing the World Health Organization’s Guideline Development Group has updated its guidance on treatments for patients with COVID-19. The new recommendations published by The BMJ are part of a living guideline, developed by the World Health Organization with the methodological support of MAGIC Evidence Ecosystem Foundation, to provide up

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2023-11-10

Leading cardiologists reveal new heart disease risk calculator

Cardiovascular, kidney and metabolic health measures included in new PREVENT risk calculator, detailed in a new American Heart Association Scientific Statement Statement Highlights: A new calculator estimates a person’s risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the first time, according to a

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2023-11-09

New Study: Gargling and Nasal Rinsing with Salt Water May Help Prevent Covid Hospitalization

Hospitalization rates in people with saline regimens significantly lower than in reference population  As Covid and its health effects move into a fourth year, those who become infected may be searching for remedies to improve their respiratory symptoms and keep them out of the hospital. A new study being presented at this year’s American College

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2023-11-07

New study findings call into question the superiority of stem cell therapy for treating knee pain

Characterized by extensive damage to joints and debilitating pain, osteoarthritis (OA) impacts millions of people worldwide and has long posed a substantial clinical and economic burden. In spite of advances in diagnosis, medications, and short-term pain management solutions, the elusive goal of a disease-modifying OA drug has remained out of reach. In recent years though,

Read More

No Comments InCELL THERAPY REGENERATIVE MEDICINE
PIER MARIA FORNASARI
2023-11-05

Study finds that 20–25 minutes of daily physical activity may offset death risk from prolonged sitting

Clocking up just 20–25 minutes of physical activity every day may be enough to offset the heightened risk of death from a highly sedentary lifestyle, suggests research published online in the British Journal of Sports Medicine. But higher daily tallies of physical activity are linked to a lower risk, irrespective of the amount of time spent

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2023-11-05

Convalescent plasma reduces mortality by 10% in Covid-19 patients in acute respiratory distress and on artificial respiratory assistance

In a study published in The New England Journal of Medicine, clinicians and researchers from the CHU of Liège and the University of Liège show that the administration of plasma taken from convalescent donors after infection with Sars-CoV-2 to patients suffering from acute respiratory distress syndrome requiring artificial mechanical ventilation significantly reduced mortality (10%). he randomised

Read More

No Comments InCovid-19